Trials
DUBLIN, IRELAND: Principal Purpose of the Meeting Is to Take Actions Relating to Horizon Pharma's Proposed Acquisition of Depomed, Inc. ...
WOBURN, MA: Will Exhibit at the World ADC 2015, Oct. 19-22 in San Diego, Booth #18 ...
DUBLIN, IRELAND: Intends to Solicit Proxies From Depomed Inc. Shareholders for the Removal and Replacement of Depomed's Current Board and the Repeal of a Series of Recent Amendments to Depomed's Bylaws ...
DUBLIN, IRELAND: Phase 1 Trial of Potential Best-in-Class Neprilysin Inhibitor Planned for Q4 2015; Compound Designed for Broad Use in Major Cardiovascular and Renal Diseases ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/07/15 -- (OTCQB: TTNPD), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 09/25/15 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company"), a leading immuno-oncology company, announces that Marc Voigt ...
DUBLIN, IRELAND: Company Seeks Expanded Label Supporting VIBATIV Use Against Concurrent Bacteremia in Cases of Complicated Skin and Skin Structure Infections (cSSSI) or Hospital-Acquired and Ventilator-Associated Bact ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/03/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...
DUBLIN, IRELAND: Represents the 13th Allowed U.S. Patent for PENNSAID 2% ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 07/30/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that Rick E Winningham, Chairma ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 07/06/15 -- Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer of Kadmon, will present at the Cantor Fitzgera ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 06/23/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and comm ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 06/19/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and comm ...
BOTHELL, WA: Company to Present at the Partnering Forum During the 2015 BIO International Convention ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/27/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 05/26/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and bus ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/08/15 -- . (OTCBB: TTNP) today announced that it will host a live conference call at 1 p.m. EDT / 10 a.m. PDT on Thursday, May 14, 2015 to discuss the c ...
GEORGE TOWN, GRAND CAYMAN: VIBATIV(R) Commercial Activities Gaining Momentum; TD-4208 Phase 3 Program to Commence Second Half 2015; New Product Candidates Advancing Towards the Clinic; Lowering Operating Loss Guidance for 2015 ...
